Prostate Cancer | Tumor

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Less May Be More in Prostate Cancer Treatment

September 20th 2017

A clinical trial will test whether partial prostate ablation matches radical prostatectomy in effectiveness — with fewer early side effects.

PSA Screening Rates Are No Longer Dropping

September 20th 2017

After a drop, the frequency of PSA screening for prostate cancer has stabilized.

Active Surveillance Is Best Bet for Low-Risk Prostate Cancer

September 19th 2017

Study: To prolong survival in early-stage prostate cancer that is low-risk, observe instead of operating.

Can an Ovarian Cancer Drug Work in Prostate Cancer?

September 19th 2017

A targeted drug for women with ovarian cancer may also benefit men with prostate cancer who have similar genetic mutations. A phase 3 trial is designed to find out.

FDA Approves Jevtana for Prostate Cancer Subset

September 18th 2017

Jevtana (cabazitaxel) was granted approval by the Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant prostate cancer who previously received a docetaxel-containing regimen.

Better Calculating the Aggressiveness of Prostate Cancer

September 15th 2017

Scientists are looking for more and better ways to identify the prostate cancers that are most likely to become aggressive.

Exploring the Link Between Stroke and Cancer

September 14th 2017

Stroke survivors were diagnosed with cancer at almost double the rate of incidence in the general population, one study showed.

Jim Kelly's Cancer Journey: Trophies, Tragedies and Triumphs

August 25th 2017

Hall of Fame quarterback Jim Kelly met with CURE to talk about his cancer experience.

Study Closes the Debate on Vasectomy- Prostate Cancer Link

July 26th 2017

For years, people believed that there was a link between vasectomies and prostate cancer.

Expert Weighs In: Active Surveillance in Prostate Cancer

June 26th 2017

When it comes to active surveillance and prostate-specific antigen (PSA) screening for localized prostate cancer, the paradigm has been shifting and the debate over which is correct has been raging on in recent years, says Andrew Stephenson, M.D.

Senate Releases Plan for Repealing Affordable Care Act, as Cancer Advocates Weigh In

June 22nd 2017

This morning, Senate Republican leaders released the draft of a bill to repeal and replace the Affordable Care Act (Obamacare).

Drug Resistance Mediated by Gene Expression in Prostate Cancer

June 22nd 2017

Inhibiting the ABCB1 gene with antiandrogen therapy – such as Xtandi (enzalutamide) and Casodex (bicalutamide) – may be the answer to increasing efficiency of tanxane-based therapies.

Long-Term Quality of Life Effects Seen in Survivors More Than 10 Years After Prostate Cancer Treatment

June 6th 2017

A new study published in Cancer Medicine examined the long-term health-related effects of definitive treatment for patients with localized prostate cancer and found that they continue more than 10 years after treatment.

Zytiga Can Be Paradigm-Shifting for Prostate Cancer Treatment

June 5th 2017

Some newly diagnosed patients with prostate cancer reduced their risk of death with earlier use of Zytiga, according to two trials presented at the ASCO Annual Meeting.

More Early Cancers Diagnosed After the Affordable Care Act

May 19th 2017

After the Affordable Care Act was passed, a study found that there were more stage 1 cancer diagnoses across the nation.

Recent Patterns Indicate PSA Testing Halt in Decline

May 4th 2017

Previously reported declines in prostate-specific antigen testing have not continued in recent years, and that approximately one-third of men age 50 years or older still receive routine PSA tests.

Study Calls for a Tailored Approach to Prostate Cancer Screenings in Black Men

May 2nd 2017

A recent study found that, due to higher incidence of prostate cancer in black man, PSA testing may need to be started earlier in this population, and be done more frequently.

Expert Discusses Biomarker Development in Prostate Cancer

April 28th 2017

Leonard Gomella, M.D., recommends that healthcare providers familiarize themselves with how each novel biomarker should be used and then decide which one to use for a more individualized approach in clinical practice.

USPSTF May Change Viewpoint on PSA Screening for Prostate Cancer

April 12th 2017

The USPSTF may be changing its stance on PSA screening for prostate cancer.

Examining the Link Between Prostate Cancer Treatment and Dementia

April 12th 2017

Androgen deprivation therapy, a popular treatment for prostate cancer, may have a link to dementia, according to a recent analysis.

Expert Discusses: Can Immunotherapy Be Successful in Prostate Cancer?

April 10th 2017

While other tumor types have seen extraordinary progress with immunotherapy agents such as Opdivo (nivolumab) and Yervoy (ipilimumab), they have not yet shown similar success in the treatment of prostate cancer. Padmanee Sharma, M.D., Ph.D., weighs in.

Discussing The Latest Advances in Prostate Cancer Treatment

April 7th 2017

In an interview with CURE at the Interdisciplinary Prostate Cancer Congress, Celesita Higano, M.D., discussed the early use of chemotherapy, the potential for PARP inhibitors and the evolving role of radium-223 in prostate cancer.

Shorter Length of Sleep Associated With Increased Risk of Death from Prostate Cancer

April 3rd 2017

The amount of sleep a man gets can have an impact on prostate cancer outcomes, according to a recent study.

Hitting a Nerve: Nerve Damage From Cancer Treatment Can Impair Sexual Function

March 7th 2017

Nerve and other damage from cancer treatments can impair men’s sexual function, and adjusting can be a challenge.

Personalizing Treatment With ctDNA in Prostate Cancer

February 24th 2017

Since it is found in the majority of patients with mCRPC, circulating tumor DNA may be able to lead the way to more personalized prostate cancer care.

Combination Is Active in Prostate Cancer

February 21st 2017

Durvalumab and Lynparza (olaparib) provided a response for patients in a small study.

Genetic Testing Can Predict Metastasis and Death in Prostate Cancer

February 18th 2017

The Decipher test can be used to predict death and metastases in some patients with prostate cancer, according to findings that were recently presented.

Study Supports Novel Therapy for Low-Risk Prostate Cancer

February 16th 2017

Padeliporfin vascular-targeted photodynamic therapy may be a promising option for men with low-risk prostate cancer, according to the results of a recent study.

The Essentials of Nutrition and Digestive Health in Pancreatic Cancer

February 11th 2017

The Addition of Hormone Therapy Improves Survival in Recurrent Prostate Cancer

February 9th 2017

Adding hormone therapy to radiation therapy after surgery showed significant survival improvements in a recent study involving men with recurrent prostate cancer.